Introduction to mycoplasma and cell product risks

In this webinar, Dr Tim Sandle introduces mycoplasmas and outlines the risks they present and the remediation strategies required to control the microorganisms.

 

 

Mycoplasma species are the most common contaminants in cellular therapies. This webinar introduces mycoplasmas and outlines the risks they present and the remediation strategies required to control the microorganisms.

 

Topic areas we cover include:
  • Risks posed to cellular products
  • Sterile filtration challenges
  • Surface adherence challenges
  • Sources of contamination including association with cell culture reagents
  • Remediation strategies, including donor material assessment
  • Regulations

Register for this on demand webinar

About the speaker:

 

 

Dr. Tim Sandle has over twenty-five years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and he has written over six hundred book chapters, peer reviewed papers and technical articles relating to microbiology. Dr. Sandle works for a pharmaceutical manufacturer in the UK, and is a visiting tutor at both the University of Manchester and UCL.

Contact us

Call us on either number below

Switchboard: +44 (0)118 918 4000

Customer Services: +44 (0)118 918 4076

We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.